Foundayo Tracker App
Track Your Foundayo (Orforglipron) Protocol
Foundayo (orforglipron) is Eli Lilly's oral GLP-1 pill with up to 14.7% weight loss in Phase 2 trials. Shotlee is the free app to track your complete Foundayo protocol — daily doses, side effects, weight, and labs.
25,000+
Active Users
4.8★
App Rating
Free
Always Free
What Is Foundayo?
Foundayo (orforglipron) is Eli Lilly's oral non-peptide GLP-1 receptor agonist — a once-daily weight loss pill that doesn't require injections or fasting. Phase 3 ATTAIN trials have shown meaningful weight loss, and FDA submission is underway.
Shotlee tracks every aspect of your Foundayo protocol: daily pill intake, doses, side effects, weight changes, measurements, and lab results. Whether you're starting Foundayo or optimizing your dose, clean data helps you and your prescriber make better decisions.
What to Track in Shotlee
Build a complete Foundayo protocol record from day one.
Daily Dose Log
Record every pill — date, dose amount (mg), and time taken. Daily reminders keep you consistent.
Weekly Weight
Track body weight consistently to see your response curve over time.
Side Effects
Log any side effects with severity ratings to share with your prescriber.
Lab Results
Save blood work and biomarkers (HbA1c, fasting glucose, lipids) from clinic visits.
Measurements
Waist, hip, and other body measurements reveal changes the scale may miss.
Notes & Mood
Daily notes on energy, appetite, sleep, nausea, and overall wellbeing.
How to Track Your Foundayo Protocol
Set a baseline: log your starting weight, measurements, and any available labs before your first dose
Record every daily dose: date, amount (mg), time taken, and any immediate reactions
Log weekly weight at the same time and conditions to track your trend accurately
Note side effects with severity so your prescriber can adjust your titration schedule
Add lab results from each clinic visit to measure biomarker improvements over time
Foundayo Key Facts
Administration
Once-Daily Pill
No injection, no fasting required
Dose Range
3-45 mg/day
Gradual titration from 3 mg to 36-45 mg
Protocol FAQs
Foundayo is the brand name for orforglipron, a once-daily oral non-peptide GLP-1 receptor agonist from Eli Lilly. It's a pill — no injections, no fasting requirements. Phase 3 trials show meaningful weight loss.
Open Shotlee, select Foundayo (orforglipron), and log your daily pill dose. Track weight, side effects, and labs alongside. Daily reminders keep you consistent.
Yes — Foundayo tracking is completely free forever. Premium AI features are available optionally.
Open the Shotlee app, navigate to the dose logging screen, select Foundayo as your medication, and enter the dose amount and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts.
Track gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider.
Most patients notice appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule. Track your weekly weight in Shotlee to visualize your personal response curve.
References
Track Your Foundayo Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
🚀 Use Shotlee for Free